Cargando…
Correlation Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Programmed Death-Ligand 1 Expression as Prognostic Markers in Non-Small Cell Lung Cancer
Background The neutrophil-to-lymphocyte ratio (NLR) at baseline treatment is an important marker of systemic inflammation, which is correlated with survival benefits in lung, breast, ovarian, bladder, and colorectal cancer. Programmed death-ligand 1 (PD-L1) expression is a biomarker with discording...
Autores principales: | Pirlog, Cristina-Florina, Cotan, Horia Teodor, Parosanu, Andreea, Orlov Slavu, Cristina, Popa, Ana Maria, Iaciu, Cristian, Olaru, Mihaela, Oprita, Alexandru Vlad, Nita, Irina, Nitipir, Cornelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375517/ https://www.ncbi.nlm.nih.gov/pubmed/35974841 http://dx.doi.org/10.7759/cureus.26843 |
Ejemplares similares
-
Restricted Mean Survival Time—Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors?
por: Pîrlog, Cristina-Florina, et al.
Publicado: (2023) -
Desensitization Protocol to Carboplatin: A Technical Report
por: Nitipir, Cornelia, et al.
Publicado: (2022) -
Nivolumab Hypersensitivity Reactions a Myth or Reality in Solid Tumors—A Systematic Review of the Literature
por: Pîrlog, Cristina-Florina, et al.
Publicado: (2022) -
Prognostic Models for Renal Cell Carcinoma in the Era of Immune Checkpoint Therapy
por: Parosanu, Andreea, et al.
Publicado: (2022) -
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma
por: Parosanu, Andreea Ioana, et al.
Publicado: (2023)